|
obrixtamig Clinical Trials
3 actively recruiting trials across 3 locations
▲ +1 trial since September 2026
Also known as: BI 764532
Pipeline
Phase 3: 2Phase 1/2: 1
Top Sponsors
- Boehringer Ingelheim3
Indications
- Cancer3
- Lung Cancer2
- Advanced Small Cell Lung Cancer1
- Extensive-stage Small Cell Lung Carcinoma1
- Extrapulmonary Neuroendocrine Cancer (epNEC)1
Mobile, Alabama1 trial
Scottsdale, Arizona1 trial
Miami, Florida1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.